Siren LLC’s RAPT Therapeutics RAPT Stock Holding History

Siren LLC’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,375,000	Closed	-$46.6M	–	120
2025 Q4	$46.6M	Buy	1,375,000 +794,534	+137%	+$24.7M	1.39%	23
2025 Q3	$15M	Buy	+580,466	New	+$7.6M	0.59%	40

Siren LLC's RAPT Position: Q1 2026 in Review

Siren LLC sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 1,375,000 shares — an estimated $46.6M sold.

Siren LLC first reported a position in RAPT in Q3 2025 and held it in 2 quarters. The position peaked at $46.6M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Siren LLC reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Siren LLC sold 1,375,000 RAPT Therapeutics shares in Q1 2026, an estimated $46.6M.
Siren LLC first reported a position in RAPT Therapeutics in Q3 2025 and held it in 2 quarters.
Siren LLC's RAPT Therapeutics position peaked at $46.6M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Siren LLC's 13F filing for Q1 2026, filed 14 May 2026.